Old Web
English
Sign In
Acemap
>
authorDetail
>
A. Eldred
A. Eldred
AbbVie
Enthesitis index
Kyowa hakko
Skin symptoms
Bone erosion
Physical therapy
3
Papers
42
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
OP0228 EFFICACY AND SAFETY OF RISANKIZUMAB FOR ACTIVE PSORIATIC ARTHRITIS, INCLUDING PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC THERAPIES: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND, KEEPSAKE 2 TRIAL
2021
Annals of the Rheumatic Diseases
A. Ostor
F. van den Bosch
Kim Papp
C. Asnal
Roman Blanco
Jacob A. Aelion
G Alperovich
Y. H. Zhang
Z. Wang
A. M. Soliman
A. Eldred
Alan Kivitz
Show All
Source
Cite
Save
Citations (1)
AB0559 EFFICACY AND SAFETY OF RISANKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AFTER INADEQUATE RESPONSE OR INTOLERANCE TO DMARDs: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND KEEPsAKE 1 TRIAL
2021
Annals of the Rheumatic Diseases
L. E. Kristensen
M. Keiserman
Kim Papp
L. Mccasland
D. White
L. Barcomb
W. Lu
Z. Wang
A. M. Soliman
A. Eldred
Frank Behrens
Show All
Source
Cite
Save
Citations (2)
OP0307 Efficacy and safety of risankizumab, a selective il-23p19 inhibitor, in patients with active psoriatic arthritis over 24 weeks: results from a phase 2 trial
2018
Annals of the Rheumatic Diseases
P.J. Mease
H. Kellner
A. Morita
A.J. Kivitz
Kim Papp
S Aslanyan
B. Berner
S. Chen
A. Eldred
Frank Behrens
Show All
Source
Cite
Save
Citations (39)
1